Anew report titled "Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease" issued by the Institute of Medicine (I.O.M.) asserted standards of evidence used by the Food and Drug Administration when evaluating the health benefit claims offood ingredients and dietary supplements should be as scientifically rigorous as those it employs when evaluating drugs. "Few who are allergic to peanuts, eggs or shellfish would argue that foods are less risky than drugs," the report's authors said. "The committee concludes that there is neither rationale nor scientific grounds for basing regulatory decisions on different levels of scientific evidence for different substances -- science is science."
展开▼
